Switzerland
Swiss Drug Manufacturers—Specialty & Generic Industry Analysis
Benchmark and data visualization of Swiss public listed companies in the Drug Manufacturers—Specialty & Generic Industry, with top companies, stocks performance comparison, competitive analysis, and comparisons of top companies for market research.
Switzerland public listed companies in the Drug Manufacturers—Specialty & Generic industry: 4
Switzerland Drug Manufacturers—Specialty & Generic total companies market cap (USD): $16.56 Billion
format_list_bulleted
List of Swiss Drug Manufacturers—Specialty & Generic Companies
Switzerland Analysis
Top Swiss Companies
language World Companies Analysis language World Top Companies
⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes
$10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.
Largest 4 Companies in the Swiss Drug Manufacturers—Specialty & Generic Industry by Market Cap
Top 4 Swiss Drug Manufacturers—Specialty & Generic Industry Companies Details as of Jan. 11, 2021
| Company | Market Cap (USD) | Country | Sector | Industry |
|---|---|---|---|---|
| Vifor Pharma AG |
$11.57 B
(Dec. 1, 2022) |
Switzerland
|
Healthcare
|
Drug Manufacturers—Specialty & Generic
|
| Siegfried Holding AG |
$4.12 B
(Jan. 1, 2026) |
Switzerland
|
Healthcare
|
Drug Manufacturers—Specialty & Generic
|
| PolyPeptide Group AG |
$876.3 M
(July 1, 2025) |
Switzerland
|
Healthcare
|
Drug Manufacturers—Specialty & Generic
|
| SES Solar, Inc. | $None |
Switzerland
|
Healthcare
|
Drug Manufacturers—Specialty & Generic
|
format_list_bulleted
List of Companies: Switzerland Drug Manufacturers—Specialty & Generic